Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ewing, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
ANTARES PHARMA, INC. has filed 1,187 SEC EDGAR filings since 24 Jun 1996

SEC filing history

Showing 76-100 of 688 matching filings.

Per page
25
Current page
4
4

FORM 4

Filing date
04 Mar 2022
Reporting date
03 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Feb 2022
Reporting date
16 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-47575

SC 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
04 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-47575

SC 13G/A filing

Filing date
01 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Oct 2021
Reporting date
27 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
29 Oct 2021
Reporting date
27 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Aug 2021
Reporting date
27 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jul 2021
Reporting date
08 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-257345

S-8

Filing date
24 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .